Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Topline The Centers for Medicare and Medicaid Services proposed limiting coverage for Alzheimer’s drug Aduhelm to patients participating in clinical trials Tuesday, after many medical experts claimed ...

Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success

Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...